{
    "address": "Ronnowsgatan 8 C",
    "city": "Helsingborg",
    "country": "SE",
    "currency": "SEK",
    "cusip": "W7888E106",
    "description": "Expres2ion Biotech Holding AB engages in the development and manufacture of drugs. The company is headquartered in Helsingborg, Skane. The company went IPO on 2016-07-29. The firm specializes in developing cell lines and processes based on a non-viral Drosophila S2 cells expression system. The firm's ExpreS2 recombinant protein expression platform supports all phases of drug discovery, research and development and manufacturing. ExpreS2 is a non-viral insect cell expression system that establishes stable polyclonal pools that provide high-protein expression levels without selection pressure. The system is designed for transient or stable transfections using vector deoxyribonucleic acid containing a hybrid promoter. The company also ensures high cell density without aggregation or toxic metabolite build-up issues. Through the joint venture AdaptVac ApS, the Company applies a Plug-and-Play Virus Like Particle technology for development of therapeutic and prophylactic vaccines within oncology, infectious diseases and immunological disorders.",
    "employeeTotal": "",
    "exchange": "NASDAQ OMX NORDIC",
    "finnhubIndustry": "Biotechnology",
    "ggroup": "Pharmaceuticals, Biotechnology & Life Sciences",
    "gind": "Biotechnology",
    "gsector": "Health Care",
    "gsubind": "Biotechnology",
    "ipo": "2016-07-29",
    "isin": "SE0008348262",
    "logo": "",
    "marketCapitalization": 1160.048,
    "naics": "Pharmaceutical and Medicine Manufacturing",
    "naicsNationalIndustry": "Biological Product (except Diagnostic) Manufacturing",
    "naicsSector": "Manufacturing",
    "naicsSubsector": "Chemical Manufacturing",
    "name": "ExpreS2ion Biotech Holding AB",
    "phone": "",
    "sedol": "BD08770",
    "shareOutstanding": 27.608301,
    "state": "SKANE",
    "ticker": "EXPRS2.ST",
    "weburl": ""
}